Concepedia

Massimiliano Lanfranco

ML

Statistics

Publications

7

Citations

166

H-Index

7

Active since

2014

Affiliations

Italian Institute of Technology(Current)

University of California, Irvine

University of Genoa

Sorrento Therapeutics (United States)

Angelini Pharma (Italy)

Massimiliano Lanfranco is an author at Italian Institute of Technology specializing in medicine, neurology, and neuropharmacology.

Top concepts

Publications per year

2014–2020

7

Publications

7

Second‐Generation Non‐Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis

Marco Migliore, Silvia Pontis, Ángel L. Fuentes de Arriba et al. · Angewandte Chemie International Edition · 2016 · 49 citations · Full text

Hit Optimization of 5-Substituted-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders

Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla et al. · Journal of Medicinal Chemistry · 2015 · 41 citations · Full text

, , +19

Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central<scp>CCL</scp>5 overproduction

Silvia Di Prisco, Elisa Merega, Massimiliano Lanfranco et al. · British Journal of Pharmacology · 2014 · 19 citations · Full text

N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis

Silvia Pontis, Francesca Palese, Maria Summa et al. · Pharmacological Research · 2020 · 17 citations

, , +6

Second‐Generation Non‐Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis

Marco Migliore, Silvia Pontis, Ángel L. Fuentes de Arriba et al. · Angewandte Chemie · 2016 · 15 citations

, , +17

1–5 of 7